Phospholamban is a critical repressor of myocardial contractility, and targeting its inhibitory action represents a potential therapeutic strategy for heart failure.
No takes yet. Share an insight, caveat, or question.
Targeting phospholamban may offer heart failure therapy; leaves open clinical validation in trials.
Koss et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: